CURRENT PLEDGES: 217670

Antibiotic Guardian Logo

Shared Learning 2025 – Tackling Health Inequalities in AMR

Organisation

NHS West Yorkshire ICB

Project title: Developing a framework for Co-production to prevent Antimicrobial Resistance (AMR) in the Roma Population in West Yorkshire.

Project Overview

The mission of Integrated Care Systems is to reduce inequalities and tackle unwarranted variations in care. Antimicrobial Resistance (AMR) further complicates this, especially in West Yorkshire (WY), where socioeconomic factors heighten infection risks and AMR vulnerability. AMR is a particularly pertinent issue for Roma communities who, due to health inequalities, are at an increased risk of infection, often buy and share unprescribed antimicrobial drugs, have poor knowledge of infection prevention, and due to experience extensive barriers to healthcare. We also recognized that health care workers had poor cultural awareness of Roma community and a lack of representation of Roma Community in participation groups.

Previous work had focused on infection prevention, hydration awareness, AMR reduction; helping Roma people to recognise symptoms and live with infection in their homes; thus, reducing hospital admissions and improving patient safety and experience. However, we identified that for stewardship advice to be effective, we needed to help the community understand the importance of antibiotics; when they are required, and how these drugs can be accessed safely through prescription, addressing both medical needs and broader social health determinants.

A small project team enrolled on a New Citizen Project “Participation in Action” program to identify and develop skill on how to best work with people and communities to prevent infections, and ultimately, reduce AMR. Through this work we used tools and techniques to articulate the question we wanted to work with, learning steps of discovering, defining, developing and delivering in collaborative, truly participatory ways. After gaining insight from several health professionals and VSCE organisations, we developed a co-production group with three Roma community interest groups, building understanding and trust to work together on AMR reduction and reduce inequalities in antimicrobial stewardship.

Impact on tackling AMR

Engaging with communities and building strong relationships has fostered long-term collaboration and trusted networks across West Yorkshire to support AMS/IPC initiatives. This approach enabled enhanced Needs Assessment and Gap Analysis efforts with Migrant, Asylum Seeker, Gypsy, Roma, and Traveler communities, addressing barriers to screening and immunizations. Roma communities are now actively involved in all aspects of AMS/IPC engagement, from awareness days to educational activities tailored for families, including school events, pre-school sessions, and post-school drop-ins. These achievements celebrate the power of collaboration in creating inclusive, impactful health interactions. The Roma community emphasized the value of verbal translations and pictorial resources in improving message accessibility, reducing misunderstandings, and reaching a wider audience. Community members even brought medication boxes purchased locally without prescriptions, helping the project team identify antibiotics, explain their appropriate use, and stress the importance of taking them only when prescribed. Public awareness campaigns have been central to the Partnership’s AMR prevention strategy, including animation films on recognising UTIs, preventing infections through hydration and hygiene, and supporting carers’. Through co-production, community members enriched these resources with Eastern European translations, ensuring accessibility. The films have since been shared widely via social media and Romanian YouTube news channels, expanding impact. It was crucial to develop strategies to overcome stigma, language, and cultural barriers. With community support, we hosted “Health Awareness” days, enabling community pharmacy colleagues to inform attendees about Pharmacy First opportunities. They explained how infectious disease assessments could be conducted via telephone, with translators from community interest groups present. This familiar approach-built trust with local pharmacies, fostering meaningful behavioural change and improving access to safe antibiotics and healthcare. Additionally, Roma citizens were referred to the London School of Hygiene and Tropical Medicine, where they now contribute to a citizens’ forum on Pharmacy First and healthcare access alongside other PPIE representatives.

Future Development

We plan to co-produce AMS teaching packs with community leaders to address barriers and enhance healthcare practices for Roma communities. A Roma directory will be developed to support networking and strengthen connections across support networks. Additionally, we aim to establish a participation framework to engage other vulnerable communities in AMS/IPC prevention strategies. These initiatives will focus on fostering collaboration, improving access to healthcare, and driving meaningful behavioural change through shared learning and community-led solutions.

Organisation

NHS England

Project title: Health and Justice Antimicrobial Stewardship

Project Overview

Background: NHS England commissions healthcare services in 147 Health and Justice Settings (HJS), aiming to provide equitable care for detained populations who experience significant health inequalities. This project explored antibiotic prescribing patterns and healthcare professionals’ views within HJS. This work represents a collaborative effort between UKHSA, NHS England, academic research partners, and health and justice teams. The goal was to identify challenges, opportunities, and targets for antimicrobial stewardship (AMS) interventions, comparing HJS antibiotic prescribing to primary care (PC) data in England.

Methods: Using the SystemOne clinical system, prescribing data from HJS for 2023-2024 was analysed alongside PC data from ePACT2 and PrescQIPP. A survey based on the COM-B model (Capability, Opportunity, Motivation, and Behaviour) assessed 24 HJS healthcare professionals’ knowledge and attitudes towards AMR.

Results: The data revealed significant variations in prescribing patterns across HJS. Data showed higher proportions of broad-spectrum antibiotic use in HJS (10.6%) compared to PC (7.7%). HJS had significantly higher percent lymecycline and metronidazole prescribing. Prescribing durations often diverged from NICE guidelines, with significantly fewer 5-day courses in HJS compared to PC. The survey identified barriers: limited motivation for AMS, professional-patient relationship dynamics, and challenges specific to acne and skin infection management. Pharmacy professionals constituted 54.2% of respondents, with overall strong AMR knowledge. Motivation to implement AMS strategies, however, was lower than capability or opportunity, particularly regarding acne management.

Conclusion: This project provides the first comprehensive analysis of prescribing behaviours in HJS and highlights key AMS intervention targets: reducing broad-spectrum use, improving management of skin infections and acne, and aligning prescribing durations with guidelines. Tailored AMS strategies designed for this unique healthcare setting include:
Antibiotic formulary updates to improve antibiotic choice and duration by prescribers.
Empowerment of pharmacy teams to query longer courses.
Support for review of antibiotics used in acne management.

Impact on tackling AMR

  1. Formation of an AMS steering group for health and justice healthcare professionals who coproduced a toolkit of AMS interventions including the SystemOne AMS formulary pack, communications to different healthcare professionals and the pharmacy antimicrobial prescription intervention pathway.
  2. Radio broadcast interview and prisoner Q&A about antibiotics and antimicrobial resistance on prison radio – content provided by the AMS steering group.
  3. Ongoing surveillance and reporting of antibiotic use in heath and justice settings and impact of AMS interventions. This will support commissioning assurance, quality improvement and peer to peer practice outcome analysis, as well as sharing learning through publications.

Future Development

  1. Patient engagement with people previously in touch with the criminal justice system (facilitated by Revolving Doors) to design patient-facing information to support shared decision making on antibiotic use and review.
  2. Research into dermatological health within the detained estate. The research question is: What factors influence healthcare professionals’ ability to effectively prevent and treat dermatological conditions amongst males in detained estates? This study evaluates the role of healthcare professionals in improving dermatological health within prisons. It explores social, behavioural, and institutional factors affecting healthcare professionals’ ability to prevent and treat skin conditions in prisons, acutely focusing on acne. This study addresses the broader challenge of health equity within the justice system and builds on existing pharmacological care research.
  3. Co-production of further interventions to promote AMS in HJS informed by the outcomes above

Organisation

Beacon House Primary Health Care for the Homeless

Project title: Moving Care Upstream

Project Overview

At Beacon House Clinic, we have long recognised the disproportionate use of antibiotics within the homeless population. Studies indicate that homeless individuals are at a higher risk for infections like pneumonia, urinary tract infections, and skin conditions, which often require antibiotic treatment. The difficulty in accessing timely healthcare exacerbates the situation, leading to more severe conditions and increased antibiotic use. Research shows that the homeless are more likely to be hospitalised for infections, with one study revealing that they are 3.5 times more likely to require hospital admission for such conditions compared to the general public.

MOVING HEALTH CARE UPSTREAM
In response to this challenge, Beacon House embarked on a project in collaboration with NHS England over the past 18 months to address the root causes of high antibiotic usage. Our initiative focused on moving care upstream through increased vaccination uptake to prevent infections in the first place. Vaccines, including those for pneumonia, influenza, and meningitis, have proven effective in reducing infections that typically require antibiotics. However, vaccination rates among the homeless population have historically been low. Public Health England has highlighted that homeless individuals are less likely to receive vaccinations compared to the general population.

To combat this, we introduced a comprehensive approach. On every first visit, patients are screened for vaccine status, and all recommended vaccines are offered. In addition, we implemented educational sessions, outreach activities, and promotions with giveaways to raise awareness about the importance of vaccinations. These initiatives have been designed to make vaccines more accessible and improve patient understanding.

Our efforts are actively contributing to reducing antibiotic use among this vulnerable group. By tracking our vaccination uptake and aiming for continued improvement, we are committed to both enhancing public health and supporting antimicrobial stewardship in the homeless community.

Impact on tackling AMR

The impact of Beacon House Clinic’s vaccination initiative has been significant in improving health outcomes for homeless individuals. Here are three key points reflecting the success of our project:

50% Vaccine Uptake: We have achieved a 50% vaccination acceptance rate among homeless patients, a significant improvement compared to national vaccine uptake rates. For instance, the flu vaccine uptake for the general population in the UK for the 2022-2023 season was 80.7%, indicating a gap but showing our success in a high-risk group.

Reduced Risk of Infections: By offering vaccinations such as the flu and pneumococcal vaccines, we have contributed to reducing the incidence of vaccine-preventable diseases among the homeless population. This not only helps prevent infections that typically require antibiotics but also supports overall health improvement, potentially reducing hospital admissions related to pneumonia and other preventable infections.

Increased Awareness of Preventive Care: Through our educational sessions, outreach, and on-site vaccine offerings, we have successfully raised awareness about the importance of preventive care. This approach has empowered homeless individuals to take proactive steps in managing their health, potentially reducing the reliance on emergency services and improving their long-term health outcomes.

These efforts have demonstrated positive results in reducing the need for antibiotics and increasing overall vaccine uptake within this vulnerable population. We are committed to further expanding these initiatives to improve health outcomes and support antimicrobial stewardship.

Future Development

To further develop and increase the impact of our vaccination initiative, we plan to expand outreach efforts by partnering with additional local organisations and community groups to raise awareness. We will also explore innovative digital platforms to engage with homeless individuals, ensuring better access to health information and vaccines. Additionally, we aim to increase our vaccination uptake by tailoring educational sessions to specific groups within the homeless population, addressing their unique needs. Sharing our good practice through national networks, such as NHS England and local health forums, will help extend the reach of our approach, promoting broader adoption across similar services.

NHS West Yorkshire ICB

NHS England

Beacon House Primary Health Care for the Homeless